Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 1, 2008, Pages 110-112

  Jones, Ronald N ^a,b   Biedenbach, Douglas J ^a   Ambrose, Paul G ^c   Wikler, Matthew A ^d  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

^d Pacific Beach BioSciences   (United States)

Author keywords

DW 224a; N. gonorrhoeae; Resistance; Zabofloxacin

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; DW 224 A; PENICILLIN G; QUINOLONE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG; ZABOFLOXACIN;

AGAR DILUTION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; QUINOLONES;

EID: 49549111795     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.05.010     Document Type: Article

References (15)

1. CDC. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae-Hawaii and California, 2001. Morb. Mort. Wkly. Rep. 51 (2002) 1041-1044
2. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition, M7-A7 (2006), CLSI, Wayne, PA
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 18th informational supplement, M100-S18 (2008), CLSI, Wayne, PA
4. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Saito I., and Kawada Y. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother. 40 (1996) 1020-1023
5. Han J., Kim J.C., Chung M.K., Kim B., and Choi D.R. Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs. Biol. Pharm. Bull. 26 (2003) 832-839
6. Jones R.N., Gavan T.L., Thornsberry C., Fuchs P.C., Gerlach E.H., Knapp J.S., Murray P., and Washington II J.A. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J. Clin. Microbiol. 27 (1989) 2758-2766
7. Jones R.N., Deshpande L.M., Erwin M.E., Barrett M.S., and Beach M.L. Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods. J. Antimicrob. Chemother. 45 Suppl 1 (2000) 67-70
8. Kim E.J., Shin W.H., Kim K.S., and Han S.S. Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent. Drug Chem. Toxicol. 27 (2004) 295-307
9. Kim H.J., Seol M.J., Park H.S., Choi D.R., Seong S.K., Shin H.K., and Kwak J.H. Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae. J. Antimicrob. Chemother. 57 (2006) 1256-1258
10. Kosowska-Shick K., Credito K., Pankuch G.A., Lin G., Bozdogan B., McGhee P., Dewasse B., Choi D.R., Ryu J.M., and Appelbaum P.C. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Antimicrob. Agents Chemother. 50 (2006) 2064-2071
11. Kwon A.R., Min Y.H., Ryu J.M., Choi D.R., Shim M.J., and Choi E.C. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent. J. Antimicrob. Chemother. 58 (2006) 684-688
12. Newman L.M., Moran J.S., and Workowski K.A. Update on the management of gonorrhea in adults in the United States. Clin. Infect. Dis. 44 Suppl 3 (2007) S84-S101
13. Park H.S., Kim H.J., Seol M.J., Choi D.R., Choi E.C., and Kwak J.H. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob. Agents Chemother. 50 (2006) 2261-2264
14. Tanaka M., Nakayama H., Notomi T., Irie S., Tsunoda Y., Okadome A., Saika T., and Kobayashi I. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates. Int. J. Antimicrob. Agents 24 Suppl 1 (2004) S15-S22
15. WHO. World Health Organization. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002. Commun. Dis. Intell. 27 (2003) 488-491